Related by context. All words. (Click for frequent words.) 75 covalent drugs 67 HepDirect R 64 Katrine Bosley 63 NuMimetic TM 61 Avila Therapeutics 61 novel peptide 60 Angiocept 60 lipid nanoparticle 60 therapeutic monoclonal antibodies 60 liposomal delivery 60 topically delivered 60 therapeutic monoclonal antibody 59 Nautilus Biotech 59 anti CD3 59 Pentad TM 59 immune modulation 59 protein kinase inhibitors 59 candidate deforolimus 59 Sphingomab TM 59 Squalamine 59 THR beta agonist 58 therapeutic peptide 58 isoform selective 58 Locked Nucleic Acid LNA 58 novel immunotherapeutic 58 novel immunomodulatory 58 gastro intestinal inflammation 58 predictive biomarkers 58 small molecule tyrosine 58 investigational humanized monoclonal antibody 58 siRNA therapeutics 58 optical biosensors 58 promising anticancer 58 Nanobody ® 58 anticancer therapeutics 58 anti infective treatments 58 novel anti infective 57 immunomodulatory 57 Receptos 57 inhibit metastasis 57 antisense drug 57 HCV protease inhibitors 57 accumulate preferentially 57 proprietary PEGylation 57 delivery polymer matrix 57 PDE# inhibitors 57 NEUGENE R 57 ENMD # 57 neuronal nicotinic receptor NNR 57 Fc fusion protein 57 JAK2 inhibitor 57 Hedgehog signaling pathway 57 selectively inhibit 57 targeting CD# 57 Symadex 57 novel antiviral therapeutics 57 RNA antagonists 57 novel peptides 57 humanized monoclonal antibodies 57 PI3K/mTOR 57 signal transduction inhibitor 57 molecular imaging radiopharmaceutical 57 systemic RNAi 57 epothilones 57 BioSET 56 antisense drugs 56 antisense inhibitors 56 Stapled Peptide 56 Cyclosporin 56 Locked Nucleic Acid 56 HDL Mimetic Peptide 56 oligonucleotide therapeutics 56 Aganocide ® 56 proprietary dermal 56 Virdante 56 immunotherapeutics 56 Sphingomab 56 GPR# agonist 56 HepDirect 56 targeted radiotherapeutic 56 theranostic 56 small molecule agonists 56 Maxy G# 56 multi kinase inhibitor 56 Charlesson 56 Adnectin 56 Hsp# inhibition 56 commercializing anti infective 56 small molecule defensin 56 highly selective inhibitor 56 Hsp# chaperone system 56 Novosom 56 TLR9 agonist 56 novel therapeutic antibodies 56 Nanobody 56 IAP inhibitors 56 amide hydrolase 56 DiLA2 56 Proteomika 56 novel L DOS# 56 MEK inhibitors 55 Alfacell proprietary ribonuclease 55 neuronal nicotinic receptors NNRs 55 nanomedicines 55 AAG geldanamycin analog 55 commercialize OncoGenex lead 55 VaxImmune 55 small molecule modulators 55 ART# 55 potently inhibit 55 novel immunotherapies 55 kidney urologic 55 protein receptors lectins 55 HCV protease 55 FGFR 55 JAK#/JAK# 55 sd rxRNA 55 anti fibrotic 55 Factor Receptor 55 Presents Preclinical Data 55 DiLA2 platform 55 novel antibody therapeutics 55 siRNA delivery 55 tiapamil 55 small molecule inhibitors 55 hedgehog pathway 55 MTP inhibitor 55 INS# [001] 55 GeneICE 55 Smac mimetics 55 Kosan dependence 55 Monoclonal antibody 55 immunomodulating 55 Fleximer R 55 selective kinase inhibitor 55 Ibis T# TM 55 thalidomide Thalomid 55 rxRNA 55 tkRNAi 55 targeting PCSK9 55 engineered proteases 55 JAK inhibitors 55 Davanat 55 monoclonal antibody therapeutics 55 antiviral compounds 55 Anticalins R 55 Antisense 55 Celator 55 HuLuc# 55 GlycArt 55 PRT# 55 CYT# potent vascular disrupting 55 platform HDL Mimetic 55 Nasdaq IMGN biotechnology 55 Anidulafungin 55 PI3K/Akt pathway inhibitor 55 LymphoStat B TM 55 recombinant biopharmaceutical 54 antisense oligonucleotides 54 rxRNA ™ compounds 54 treat gastrointestinal disorders 54 Cerulean Pharma Inc. 54 oral Janus kinase 54 Pyridorin 54 novel RNAi therapeutics 54 Syrrx 54 histone deacetylase inhibitor 54 molecular chaperone regulation 54 siRNA therapeutic 54 antitumoral 54 PDE4 inhibitor 54 selective inhibitors 54 developing TB4 54 PROT biotechnology 54 iPSC technology 54 inhibit KSP 54 Selective Electrochemical Tumor Ablation 54 biased ligand 54 antibody therapeutics 54 pharmacological chaperone 54 anionic backbone 54 Fleximer 54 vaccines oncolytic virus 54 Receptors GPCRs 54 A3 adenosine receptor 54 theranostics 54 biotherapeutics 54 Systemic Delivery 54 biologic therapeutics 54 DOS# 54 specific lectin receptors 54 Nasdaq HALO biopharmaceutical 54 SuperAntibody 54 Supernus Pharmaceuticals 54 humanized anti 54 selectively inhibiting 54 selective immunoproteasome inhibitor 54 EP #R 54 Tyrima 54 selective kinase inhibitors 54 synthetic retinoid 54 liposomal formulation 54 agonistic human 54 small molecule activators 54 histone deacetylase 54 oral prodrug 54 Tykerb lapatinib 54 Therapeutic antibodies 54 adrenergic regulation 54 selective inhibition 54 diagnostic biomarkers 54 proprietary biomaterials 54 molecular biomarkers 54 VitiGam 54 Bioral 54 FOLOTYN ® 54 Anticalin 54 patented NanoStat ™ 54 commercializing therapeutic 54 anticancer compounds 54 selective androgen receptor modulators 54 Homspera TM 54 histone deacetylase HDAC 54 PharmaMar 54 highly selective endothelin 54 GVAX ® 54 Chemokine Therapeutics 54 Curaxin CBLC# 54 Aviptadil 54 anticoagulant reversing agent 53 DGAT 53 mda 7 53 acetylcholinesterase AChE 53 SMARTICLES ® 53 Promedior 53 adenosine A2A 53 vaccine GRNVAC1 53 2 methoxyestradiol 53 Active Motif 53 Sangamo ZFP technology 53 Preclinical studies suggest 53 innovative signaling pathway 53 orally administered inhibitor 53 Digna Biotech 53 Accelerated Intelligent 53 PDE# 53 Aganocide 53 M2 subunit 53 skeletal sarcomere activators 53 product platforms AZX# 53 cancer immunotherapies 53 SARMs 53 Immunotherapeutic 53 humanized monoclonal antibody 53 aptamer therapeutics 53 NYSE Amex AEN 53 UltiMAb 53 orally administered pharmacological chaperones 53 recombinant vaccines 53 fatty acid amide hydrolase 53 DsiRNA 53 candidate custirsen 53 Adenosine Therapeutics 53 Amira Pharmaceuticals 53 Beta catenin 53 prodrugs 53 ASONEP TM 53 anticancer therapies 53 Spiegelmers R 53 Nasdaq MITI biopharmaceutical 53 Viprovex TM 53 NNR Therapeutics 53 Janus kinase 53 p# inhibitor 53 commercialize microRNA 53 Advancell 53 oncolytic 53 endothelin antagonist 53 Nereus Pharmaceuticals 53 ImQuest 53 Noscira 53 GPR# agonists 53 Quark Biotech Inc. 53 GMX# 53 psoriasis rheumatoid arthritis 53 Affimed Therapeutics AG 53 HuCAL GOLD R 53 VentiRx 53 delipidation 53 Spiegelmer 53 antisense inhibitor 53 PROfusion 53 G Protein Coupled 53 immunologic diseases 53 IAP inhibitor 53 Capsulution 53 TRACON Pharmaceuticals 53 CCR9 antagonist 53 Intarcia 53 InterfeRx TM 53 Arcelis ™ 53 Cellerix 53 identify protein biomarkers 53 volociximab 53 Corixa Corporation 53 Cellzome 53 cyclin dependent kinase inhibitor 53 Nasdaq MNKD focused 53 Ostabolin C TM 53 aptamers 53 Metallophile ™ Technology 53 Restoraderm 53 Archexin 53 peripherally acting 53 ALN PCS 52 investigational monoclonal antibody 52 CB2 selective 52 telomerase therapeutic 52 Auspex Pharmaceuticals 52 imatinib Gleevec ® 52 XmAb ® 52 EndoTAG TM 52 oncolytic virus therapies 52 Campath ® 52 humanized mouse 52 Salmedix 52 Inc. NASDAQ CRIS 52 biomarker assays 52 allosteric modulation 52 Dyax phage display 52 PhiloGene 52 Cx# [002] 52 ARRY # 52 PDGF receptor 52 RECOTHROM R 52 DepoVax 52 buccal delivery 52 fusion enhancers 52 RNA antagonist 52 Epizyme 52 IMiDs ® 52 enhanced skin permeation 52 investigational pan BCR 52 peptibody 52 5 HT2A serotonin 52 humanized monoclonal 52 immatics 52 Onconase 52 TRAIL receptor antibodies 52 OTCBB NRGX biotechnology 52 RenaZorb TM 52 poly ADP ribose polymerase 52 attach auristatin 52 Inc. AMEX YMI 52 Ii protein 52 YONDELIS R 52 Galenea 52 romazarit 52 PNP inhibitor 52 investigational therapies 52 iSONEP TM 52 Transfluor 52 Factor VIIa 52 taxane derivative 52 Spiegelmer ® 52 Regado Biosciences 52 KAI Pharmaceuticals 52 using VIAdel TM 52 RayBiotech 52 virosome 52 Zalypsis 52 Archemix Corp. 52 Bioral Amphotericin B 52 LNP formulations 52 MDRNA proprietary 52 novel orally administered 52 PrevOnco 52 ALN TTR# 52 neuroprotective properties 52 including Cobalamin TM 52 Aposense Ltd. 52 Inc. Nasdaq INFI 52 biased ligands 52 erlotinib Tarceva ® 52 polysaccharide polymer 52 IMiD 52 vascular disrupting agent 52 Locus Pharmaceuticals 52 MCSP respectively 52 proprietary polysaccharide 52 3 kinase PI3K 52 JAK1 52 Catalyst Biosciences 52 ArQule Kinase Inhibitor Platform 52 reversible inhibitor 52 TLR8 52 selective antagonist 52 Axenohl 52 Angiotensin Converting Enzyme 52 small molecule 52 beta secretase inhibitors 52 Curaxin 52 product candidate Lpathomab 52 MEK inhibitor 52 triggers apoptosis programmed 52 brain penetrant 52 selective orally bioavailable 52 Vaccinex 52 acne impetigo 52 pan HDAC inhibitor 52 AMPK activators 52 proprietary transdermal 52 anticancer agents 52 Tumour Vascular Disrupting Agent 52 KineMed 52 renin inhibitor 52 Merrimack Pharmaceuticals 52 Epitomics 52 nicotinic alpha 7 52 tranilast 52 Combivir Kivexa 52 ImmuneRegen BioSciences Inc. 52 intracellular protein 51 MorphoSys proprietary 51 HepeX B 51 MolecularBreeding 51 stable nucleic acid 51 Adentri 51 AKT inhibitor 51 liposome encapsulated 51 Mipomersen 51 Elixir Pharmaceuticals 51 NASDAQ ALTH biopharmaceutical 51 acadesine 51 mitotic kinesins 51 enGene 51 Quark Biotech 51 Protein Kinase C 51 Hsp# chaperone 51 JAK2 kinase 51 Transfection Reagent 51 Novasome R 51 Inc. Nasdaq VIAP 51 neuro inflammatory 51 Cellerant Therapeutics 51 microRNA therapeutics 51 class mGluR5 inhibitor 51 AC Immune 51 Personalized Immunotherapy 51 humanized antibodies 51 immunotherapies 2A/Furin 51 acetonide FA 51 antiangiogenesis therapies 51 HSP# inhibitors 51 Hybridon 51 RONDEL ™ 51 HuMax TAC 51 Prodarsan R 51 mitogen activated ERK kinase 51 MP4 molecule 51 polymerase inhibitors 51 HepDirect prodrug 51 novel VDA molecule 51 LPA1 51 Akebia Therapeutics 51 MPH AMEX 51 Revimmune TM 51 selectively inhibited 51 POTELLIGENT R 51 chimeric monoclonal antibody 51 Intellikine 51 PEG irinotecan 51 RNAi therapeutic 51 Affilin ® 51 OTCBB CHKT biotechnology 51 Etubics 51 antiangiogenic agent 51 ErbB3 HER3 51 biotherapeutic 51 ophthalmic therapeutics 51 oral ghrelin agonist 51 biomodulator 51 infectious diseases autoimmune diseases 51 Cyto Pulse 51 eligen 51 Ercole Biotech 51 commercializing aptamer therapeutics 51 DermaVir Patch 51 PEGylation 51 Allosteric 51 Sousa Faro 51 Panzem R 51 bioadhesive polymer core 51 intracellular signaling pathways 51 induce apoptosis 51 SMaRT ™ 51 enhance ApoA 51 CEQ# 51 PDE4 modulators 51 Dr. Aiping Young 51 RONDEL TM 51 Recombinant Human 51 Therapeutic Vaccine 51 sulfonylhydrazine class 51 bioinnovation 51 Cellgate Inc. 51 ATRA IV 51 fibrotic disorders 51 Posiphen TM 51 RNAi therapeutic targeting 51 ALK inhibitors 51 TLR9 agonists 51 leukotriene pathway 51 HGS ETR2 51 engineered RAP peptides 51 oral JAK1 51 intranasal vaccines derived 51 Solazed TM 51 TÎ ² 4 51 Amunix 51 Chronogen 51 Taligen Therapeutics 51 Exelixis compounds 51 Initiates Enrollment 51 P#X# 51 humanized therapeutic 51 Nasdaq CGEN 51 YONDELIS 51 stem cell mobilizer 51 Cenomed 51 Captisol ® 51 OXIGON TM 51 DNAi 51 lentiviral vector 51 miRNA therapeutics 51 Aurora kinase 51 staphylococcal vaccine 51 Cobalamin TM mediated 51 Epothilones 51 herpes simplex viruses 51 AEMD 51 OTCBB CVBT 51 lipid nanoparticles 51 HGS ETR1 mapatumumab 51 Epidermal Growth Factor 51 HCV polymerase inhibitors 51 cardio metabolic diseases 51 Nasdaq IDIX biopharmaceutical 51 PharmaNova 51 candidates Azedra TM 51 Myolimus 51 MicuRx 51 RNA interference RNAi therapeutics 51 Collategene 51 siRNA compounds 51 Nexavar sorafenib 51 ALTROPANE R 51 ATL# [002] 51 myelofibrosis polycythemia vera 50 ADP receptor antagonist 50 ZFN TM 50 Inc. Nasdaq ALNY 50 Neurome 50 molecular chaperone 50 apoptosis proteins 50 oral nucleoside analogue 50 sodium glucose cotransporter 50 demonstrated antitumor activity 50 Potelligent Technology 50 proprietary intranasal insulin 50 commercialize Aganocides 50 RNA interference RNAi 50 aurora kinase 50 carbohydrate polymers 50 Raven Biotechnologies 50 ImmunoGen Inc. 50 HP Acthar R 50 Restoraderm R technology 50 acyclovir Lauriad R 50 OTCBB NRGX 50 ACTCellerate 50 otelixizumab 50 AEG# 50 treating neuropathic pain 50 Pruvel TM 50 anti amnesic 50 Creabilis Therapeutics 50 negative allosteric modulator 50 P#X# antagonist 50 Nasdaq OMER biopharmaceutical 50 Civacir 50 Vidaza ® 50 metabolite profiling 50 pathophysiological effects 50 ospemifene 50 #ME# 50 LEAD Therapeutics 50 prostone 50 RNA therapeutics 50 CAMBRIDGE Mass. Alnylam Pharmaceuticals 50 Ampakine compounds 50 adrenal steroid hormones 50 CureDM 50 GAP #B# 50 platforms GVAX 50 Spiegelmers ® 50 NASDAQ ABII 50 overactive bladder VANTAS R 50 biotherapeutic drugs 50 Uvidem 50 Endotis 50 5 HT2C 50 NovaBay Aganocide compounds 50 Angiolix R 50 ribonucleotide reductase clinically validated 50 cytoskeleton enables 50 mTOR mammalian target 50 cellular immunotherapy 50 neuroblocking technology 50 γ secretase 50 NNRs 50 Progenika 50 dermatology therapies 50 monoclonal antibodies 50 SinuNase ™ 50 alpha#beta# 50 lead molecular radiotherapeutic 50 Hsp# inhibitors 50 Anaphore 50 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 50 Pervasis 50 PEGylated Fab fragment 50 sodium glucose transporter 50 delivers sumatriptan 50 Syntonix 50 Intellect Neurosciences 50 exon skipping 50 enzymology 50 LentiVector technology 50 OTCBB PYTO 50 Bayhill Therapeutics 50 ddRNAi 50 Dalbavancin 50 histone methyltransferases HMTs 50 ZFP Therapeutics 50 neovascular diseases 50 IIB ActRIIB 50 Molecular Templates 50 Mersana 50 LHRH antagonists 50 TransVax ™ 50 RNAi compounds 50 ProNAi 50 Regulus Therapeutics 50 oral picoplatin 50 protein therapeutics 50 NTDDS 50 Santaris 50 Fibroblast Growth Factor Receptor 50 targeted radiotherapeutics 50 Pathway Inhibitor 50 Stapled Peptides 50 peptidic compound 50 oncolytic viruses 50 Gemin X 50 proprietary Dicer Substrate Technology 50 CCR1 50 peptide conjugated 50 hypoxia activated prodrug 50 polymer conjugate technology 50 MAbs targeting 50 myeloproliferative disorders 50 Reports Preclinical Data 50 peptide therapeutics 50 evaluating tivozanib 50 Aegis Therapeutics 50 monoclonal 50 siRNAs targeting 50 pralatrexate injection folate analogue 50 therapeutic antibodies 50 Reata Pharmaceuticals 50 purinergic receptors P#X# 50 Decision Biomarkers 50 reverse vaccinology 50 CRACM 50 Luteinizing Hormone Releasing Hormone 50 Sangamo ZFP TF 50 KL4 Surfactant 50 clinically validated targets 50 nitric oxide donating prostaglandin 50 nilotinib Tasigna 50 Avian Transgenic Technology 50 fibrotic diseases 50 potent inhibitor 50 Evoltra ® 50 pafuramidine maleate 50 human antibody therapeutics 50 Delta opioid receptor 50 FivePrime Therapeutics 50 EyeGate 50 biologic therapies 50 Intermezzo ® zolpidem tartrate 50 Vidofludimus 50 ALN HTT 50 immunotherapy treatments 50 stem cell therapeutics 50 derivatives Radilex TM 50 AmpliMed 50 Enanta Pharmaceuticals 50 CYCLOSET ® 50 Zymeworks 49 EyeGate Pharma 49 proven DuraSite ® 49 Wellstat 49 sirtuin therapeutics 49 AMEX KAL 49 Azedra 49 GelVac 49 NYSE Amex PBTH 49 ZEFTERA TM Zevtera TM 49 rheumatoid arthritis multiple sclerosis 49 Initiates Phase II 49 Wnt signaling pathway 49 RevGenetics 49 MacuSight 49 RECOTHROM ® 49 MEK ERK 49 Drug Discovery AIDD 49 immunological diseases 49 NS5B polymerase 49 selective androgen receptor modulator 49 novel therapeutics 49 Nasdaq LXRX biopharmaceutical 49 Provectus Pharmaceuticals specializes 49 Infectech 49 CrystalGenomics 49 DNA methyltransferase inhibitors 49 Crucell genetically engineered 49 outlicensing 49 synthetic cannabinoid compounds 49 Teplizumab 49 Crucell PER.C6 49 anti CD3 monoclonal 49 MSCRAMM ® 49 Euroscreen 49 next generation URAT1 49 hereditary emphysema 49 Epeius Biotechnologies Corporation 49 Enkephalin 49 rheumatoid arthritis thrombocytopenia 49 NanoViricides 49 Genotyping Test 49 SNALP technology 49 selective angiogenic kinase inhibitor 49 kinase inhibitor 49 inflammatory autoimmune diseases 49 CYP#A# CYP#D# 49 utilizes InSite Vision 49 Unit Dose Budesonide 49 DNA methylation biomarkers 49 BRAF kinase 49 LX# LX# LX# 49 kinase inhibitors 49 Xytis 49 R sorafenib tablets 49 ABL inhibitor 49 proprietary encapsulation 49 bioengineers novel 49 LPA1 receptor 49 Zenyaku Kogyo 49 treat male hypogonadism 49 STEDESA 49 Metabasis Therapeutics Inc. 49 epigenetic therapeutics 49 Alantos 49 aTyr Pharma 49 MT# MEDI 49 topical PTH #-# 49 Initiates Clinical Trial 49 reversible inhibitors 49 Neuraltus 49 RAS RAF MEK 49 Begins Dosing 49 mucosal vaccines 49 Akesis Pharmaceuticals 49 Marqibo TM 49 KL4 surfactant 49 receptor inhibitor 49 dermatological diseases 49 IMC #F# 49 ArQule Kinase Inhibitor 49 blood clot dissolving 49 Uli Hacksell Ph.D. 49 antibody humanization 49 Selzentry Celsentri 49 antiviral therapeutics 49 glucokinase activator 49 sodium thiosulfate STS 49 TSX YM AIM 49 Therapeutic Competitors Companies 49 PDE7 49 Protein Polymer Technologies 49 autologous cellular therapy 49 catalytic antioxidant compounds 49 RNAi therapeutic targeting PCSK9 49 VistaGen 49 XL# anticancer compounds 49 Igeneon 49 Cancidas 49 coronary stent merged 49 RAS MAPK pathway 49 outlicensed 49 KaloBios 49 antibody fragment therapeutics 49 PRNewswire FirstCall YM BioSciences 49 aerosolized AAT 49 targeted anticancer biopharmaceuticals 49 neuropathic pain metabolic diseases 49 XL# XL# XL# XL# 49 BHT DNA 49 upregulate 49 IV Busulfex 49 biodegradable nanoparticles 49 rxRNA compounds 49 Cenix BioScience 49 ZFP Therapeutic 49 Hedgehog pathway fatty acid 49 Albugon 49 Presents Preclinical 49 Cempra 49 Genstruct 49 fusion proteins 49 HuMax 49 Inc. OTCBB OXIS 49 Euronext Amsterdam GLPGA 49 AtuPLEX 49 U1 Adaptors 49 Alinia 49 synergistic combinations 49 Novartis NVS Snapshot Report 49 tPEMF tm 49 oncology therapeutics 49 Cerashield ™ 49 Files IND 49 Saegis Pharmaceuticals 49 Idera Pharmaceuticals 49 ViroChem 49 Sangamo BioSciences 49 Portola Pharmaceuticals 49 Cisbio Bioassays 49 AAV vector 49 HemoGenix 49 introduced NEUGENE 49 Vitamin D analogue 49 thymosin beta 4 49 Cetrorelix 49 commercialize deforolimus 49 phosphoinositide 3 48 induces apoptosis 48 UltiMAb TM 48 OHR/AVR# 48 CD# expressing 48 PsychoGenics 48 programs visit http:/www.bionovo.com 48 endosomal release 48 DAVANAT R 48 DP VPA 48 Jennerex 48 oral dihydropyrimidine dehydrogenase DPD 48 Soliris eculizumab 48 Gene Expression Laboratory 48 SGLT Inhibitors 48 Liprotamase 48 PRNewswire FirstCall Bionovo 48 electrochemical separations 48 CORT # 48 Fludara ® 48 sirtuin inhibitor program 48 Ore Pharmaceuticals 48 expanded autologous cellular 48 taste modulators 48 Ligand proprietary 48 TOPIGEN 48 IMiDs ® compound 48 Trophos 48 Mersana Therapeutics 48 Aerie Pharmaceuticals 48 SGLT inhibitors 48 Zoraxel TM 48 #HT# 48 neurotrophic 48 Chipscreen 48 cathepsin K inhibitor 48 sunitinib Sutent ® 48 Photodynamic Therapy PDT 48 Tß4 48 Athenagen 48 Neotropix 48 Crop BioScience 48 telomerase inhibitor drug 48 ChemoCentryx 48 small molecule inhibitor 48 HepDirect technology 48 therapeutic antibody 48 Silanes 48 OTCBB HXBM developer 48 CIMAB 48 orally disintegrating 48 Tragara Pharmaceuticals Inc. 48 small molecule thrombopoietin 48 IMPDH inhibitor 48 Cascade LifeSciences 48 botanical therapeutics 48 InterfeRx 48 Nasdaq ALNY 48 TRX1 48 Enhanze TM Technology 48 Modrenal R 48 Nasdaq HALO 48 dependent cellular cytotoxicity 48 topical anti infective 48 Salmonella vector 48 ORTHOCON 48 BioNumerik 48 Nasdaq RXII 48 including thyroiditis RA 48 preclinical 48 preclinical compounds 48 LEVADEX ™ 48 protein misfolding diseases 48 R Saizen R 48 albumin bound paclitaxel 48 mRNA antagonists 48 oral JAK#/JAK# inhibitor 48 Neurogen Corporation 48 Apoptone HE# 48 Onalta 48 CYT# novel 48 PER.C6 r 48 Bremelanotide 48 skeletal muscle contractility 48 Nanobody R 48 Pervasis Therapeutics Inc. 48 sd rxRNA compounds 48 CD# CEA 48 Atripla combines 48 oral salmon calcitonin 48 VIRxSYS 48 DPX Survivac 48 Tranzyme 48 personalized cellular immunotherapy 48 targeted immunotherapies 48 systemic RNA interference 48 PrevOnco ™ 48 Velcade bortezomib 48 NexBio 48 proprietary MSCRAMM ® 48 High Impact AMPAKINE 48 ALN TTR 48 Immunex Corporation 48 tyrosine kinase inhibitor TKI 48 NovaBay Pharmaceuticals 48 Chemokine 48 AvalonRx R 48 Eureka Genomics 48 cardiovascular metabolic 48 Nasdaq PARD biopharmaceutical 48 Callisto Pharmaceuticals Inc. 48 B lymphocyte stimulator 48 CancerVax Corporation 48 product platforms GVAX 48 Nanotope 48 CHDI Foundation 48 Fovea Pharmaceuticals subsidiary 48 Xenon Pharmaceuticals 48 immuno modulatory 48 antisense therapeutics 48 Cytokine PharmaSciences 48 optimal dosing regimens 48 ATL# [001] 48 JAK2 Inhibitor 48 PRNewswire FirstCall Neurogen 48 Vascular Wrap TM 48 c Raf kinase 48 RON Notch 48 PSN# [001] 48 Inc. Nasdaq IMGN 48 siRNA conjugates 48 Quark Pharmaceuticals 48 Genaera Corporation 48 PHX# 48 LymphoStat B belimumab 48 selective relaxant 48 immunotherapeutic approaches 48 Translation Gualveris Rosales Sánchez 48 Adrenomyeloneuropathy AMN HIV 48 neurology immunology 48 DGAT1 inhibitors 48 OTCBB CTIX